BioCardia, Inc. — Director's Dealing 2022

Jun 13, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioCardia, Inc. (BCDA;BCDAW)
CIK: 0000925741
Period of Report: 2022-06-10

Reporting Person: Altman Peter (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-10	Common Stock	P	4500	$1.46	Acquired	321197	Direct

Footnotes

F1: This transaction was executed in multiple trades ranging from $1.43 to $1.49 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.